The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBelluscura Regulatory News (BELL)

Share Price Information for Belluscura (BELL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 7.75
Bid: 7.00
Ask: 8.50
Change: 0.00 (0.00%)
Spread: 1.50 (21.429%)
Open: 7.75
High: 7.75
Low: 7.75
Prev. Close: 7.75
BELL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8 (OPD) Belluscura plc

2 Feb 2024 11:24

RNS Number : 8861B
Belluscura PLC
02 February 2024
 

AMENDMENT TO THE OPENING POSITION DISCLOSURE ?WITH RNS NUMBER 7792B, PUBLISHED AT 18.14 ON THE 1 FEBRUARY 2024.

 

Changes made to box 3(A), CORRECTION TO the total percentage holdings

 

FORM 8 (OPD)

 

PUBLIC OPENING POSITION DISCLOSURE BY A PARTY TO AN OFFER

Rules 8.1 and 8.2 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Full name of discloser:

BELLUSCURA PLC

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

BELLUSCURA PLC

(d) Is the discloser the offeror or the offeree?

OFFEROR

(e) Date position held:

The latest practicable date prior to the disclosure

23 OCTOBER 2023

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

YES

TMT ACQUISITION PLC

 

 

 

2. POSITIONS OF THE PARTY TO THE OFFER MAKING THE DISCLOSURE

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates

 

Class of relevant security:

 

Ordinary 1p shares

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

Nil

 

Nil

 

(2) Cash-settled derivatives:

 

Nil

 

Nil

 

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

Nil

 

Nil

 

 

TOTAL:

Nil

 

Nil

 

 

 

Class of relevant security:

 

Convertible Loan Note 17 February 2026 50p

 

 

Interests

Short positions

£

%

£

%

(1) Relevant securities owned and/or controlled:

Nil

 

Nil

 

(2) Cash-settled derivatives:

 

Nil

 

Nil

 

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

Nil

 

Nil

 

 

TOTAL:

Nil

 

Nil

 

 

Class of relevant security:

 

Convertible Loan Note 17 February 2026 40p

 

 

Interests

Short positions

£

%

£

%

(1) Relevant securities owned and/or controlled:

Nil

 

Nil

 

(2) Cash-settled derivatives:

 

Nil

 

Nil

 

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

Nil

 

Nil

 

 

TOTAL:

Nil

 

Nil

 

 

 

All interests and all short positions should be disclosed.

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

 

(b) Rights to subscribe for new securities

 

Class of relevant security in relation to which subscription right exists:

n/a

Details, including nature of the rights concerned and relevant percentages:

n/a

 

 

3. POSITIONS OF PERSONS ACTING IN CONCERT WITH THE PARTY TO THE OFFER MAKING THE DISCLOSURE

 

Details of any interests, short positions and rights to subscribe (including directors' and other employee options) of any person acting in concert with the party to the offer making the disclosure:

 

(a)  Beneficial holdings of the Directors of Belluscura plc, together with the interests of persons acting in concert with Belluscura plc, (including their close relatives and the related trusts of either of them) in Belluscura plc ordinary shares of 1p each

 

Name

Number of ordinary shares

% of voting share capital

Convertible Loan Note 17 February 2026 50p

%

Convertible Loan Note 17 February 2026 40p

%

Adam Reynolds

1,808,176

1.31%

25,000

0.52%

 

0.00%

David Poutney and spouse

14,255,731

10.36%

500,000

10.55%

 

0.00%

Robert Rauker

1,035,684

0.75%

0.00%

 

0.00%

Richard Piper

80,000

0.05%

0.00%

 

0.00%

Robert Fary

32,000

0.02%

525,000

11.08%

 

0.00%

Nigel Wray & Family Trusts

15,121,079

10.99%

500,000

10.55%

100,000

3.67%

Stephen Hemsley

3,070,664

2.23%

0.00%

0.00%

Dowgate Group Limited (as principal)(1)

1,230,000

0.89%

0.00%

0.00%

Lorna Tilbian

1,223,750

0.88%

0.00%

0.00%

Nambod Business Limited (2)

1,111,110

0.80%

0.00%

0.00%

Stuart Parkinson

389,998

0.28%

125,000

2.63%

25,000

0.91%

James Serjeant(3)

293,293

0.21%

25,000

0.52%

0.00%

David Lis and spouse

240,177

0.17%

0.00%

0.00%

Madeline Poutney

236,274

0.17%

0.00%

0.00%

Alice Poutney and spouse

164,607

0.11%

0.00%

0.00%

Jonathan Serjeant

164,442

0.11%

0.00%

0.00%

Simon Carter and close relatives

108,387

0.07%

10,000

0.21%

0.00%

Sandra Carter

36,444

0.02%

0.00%

0.00%

Paul Richards

36,444

0.02%

0.00%

0.00%

Belluscura Employee Benefit Trust

50,000

0.03%

0.00%

0.00%

Dowgate Capital - Discretionary Funds

4,262,705

3.09%

484,000

10.21%

0.00%

Dowgate Wealth - Discretionary Funds

4,663,629

3.39%

125,000

2.63%

0.00%

49,614,594

35.95%

2,319,000

48.90%

125,000

4.58%

 

(1) Dowgate Capital Limited, a wholly owned subsidiary of Dowgate Group Limited, is broker to both TMT Acquisition plc and to Belluscura plc, resulting in its interests in relevant securities also being disclosed in the offeree's Opening Position Disclosure. Dowgate Capital Limited is acting as financial adviser to Belluscura plc in relation to the offer. Dowgate Group Limited is deemed to be acting in concert with both Belluscura plc and TMT Acquisition plc. James Serjeant and David Poutney are both directors and shareholders of Dowgate Group Limited.

(2) Mr Nigel Wray was the settlor of Nambod Business Limited, for which Wintrust Asia Pacific Pte Ltd is the Trustee, the beneficiaries being certain charitable entities

(3) Total holdings of James Serjeant and close family members (of which 60,972 Belluscura plc shares are non-beneficial interests held by close relatives). This excludes those Belluscura Shares held by Jonathan Serjeant who is also a member of the Belluscura Concert Party. James Serjeant is a director of TMT Acquisition plc and also, a director and shareholder of Dowgate Group Limited resulting in his interests in relevant securities also being disclosed in the offeree's Opening Position Disclosure.

 

(b) Details of options held by Directors

 

Name

Maximum number outstanding

Scheme

Exercise price (£)

Date of grant

Expiry Date

Robert Rauker

1,927,199

3,656,573

 

Unapproved share option scheme

£0.065

 

£0.15

31/10/2019

 

07/5/2020

31/10/2029

 

07/5/2030

Robert Fary

400,000

Unapproved share option scheme

£0.39

16/1/2023

16/1/2033 

Patrick Strollo

100,000

Unapproved share option scheme

£0.15

07/4/2021

07/4/2031

 

 

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the party to the offer making the disclosure or any person acting in concert with it:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the party to the offer making the disclosure, or any person acting in concert with it, and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

 

(c) Attachments

 

Are any Supplemental Forms attached?

 

Supplemental Form 8 (Open Positions)

NO

Supplemental Form 8 (SBL)

NO

 

 

Date of disclosure:

24 October 2023

Contact name:

Simon Carter

Telephone number:

020 3903 7723

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FEEUUAARSRUURAR
Date   Source Headline
17th Apr 20247:00 amRNSBelluscura Concert Party
11th Apr 202410:23 amRNSHolding(s) in Company
8th Apr 20241:15 pmRNSHolding(s) in Company
5th Apr 20243:48 pmRNSIssue of Equity
2nd Apr 20247:00 amRNSTrading Update
28th Mar 20247:00 amRNSTotal Voting Rights
8th Mar 20244:36 pmRNSOffer Closed
7th Mar 20248:30 amRNSCancellation of Listing and trading
4th Mar 20247:00 amRNSAcceptances level
26th Feb 20247:00 amRNSAcceptances level
22nd Feb 20243:00 pmRNSAcceptances level, issue of equity & AIM Admission
19th Feb 20247:00 amRNSAcceptances level & offer closing
15th Feb 20243:51 pmRNSAcceptances level, issue of equity & AIM Admission
13th Feb 20247:00 amRNSDistribution Agreement & New VP North America
13th Feb 20247:00 amRNSAcceptances Level
12th Feb 20241:44 pmGNWForm 8.3 - Belluscura PLC
9th Feb 20248:16 amRNSOffer becomes wholly unconditional
8th Feb 20243:31 pmRNSAcceptances level, issue of equity & AIM Admission
7th Feb 20244:20 pmRNSOffer Unconditional (subject to AIM Admission)
7th Feb 202411:13 amRNSForm 8.3 - Belluscura Plc
5th Feb 20241:30 pmRNSResult of General Meeting
5th Feb 20247:00 amRNSAcceptances received in respect of the Offer
2nd Feb 202411:24 amRNSForm 8 (OPD) Belluscura plc
2nd Feb 202411:18 amRNSForm 8 (OPD) TMT Acquisition plc
1st Feb 20246:16 pmRNSForm 8 (OPD) TMT Acquisition plc - Amended
1st Feb 20246:14 pmRNSForm 8 (OPD) Belluscura plc - Amended
1st Feb 20242:34 pmGNWForm 8.3 - Belluscura PLC
29th Jan 202411:42 amRNSForm 8.3 - Belluscura PLC
24th Jan 20246:24 pmRNSForm 8.3 - Belluscura PLC
24th Jan 20246:17 pmRNSForm 8.3 - Belluscura
24th Jan 20246:02 pmRNSForm 8.3 - Belluscura PLC - Replacement
24th Jan 20245:49 pmRNSForm 8.3 - Belluscura PLC
24th Jan 20243:25 pmRNSForm 8.3 - Belluscura plc
24th Jan 20243:14 pmRNSHolding(s) in Company
24th Jan 202410:45 amRNSForm 8.3 - Belluscura Plc
23rd Jan 20246:06 pmRNSForm 8.3 - Belluscura plc
23rd Jan 20245:39 pmRNSForm 8.3 - BELLUSCURA PLC
19th Jan 20241:30 pmRNSPosting of Offer Document and Circular
8th Jan 20241:01 pmGNWForm 8.3 - Belluscura PLC
22nd Dec 202312:10 pmRNSExtension to deadline for posting Offer Document
20th Dec 20237:00 amRNSChinese registration and Trading Update
19th Dec 20231:04 pmGNWForm 8.3 - Belluscura PLC
13th Dec 20232:43 pmGNWForm 8.3 - Belluscura PLC
12th Dec 20237:00 amRNSBelluscura Receives Approval in Singapore
28th Nov 20235:00 pmRNSExtension to deadline for posting Offer Document
24th Nov 20232:06 pmGNWForm 8.3 - Belluscura PLC
16th Nov 202312:20 pmRNSForm 8.3 - Belluscura PLC
16th Nov 202312:12 pmRNSForm 8.3 - Belluscura PLC
9th Nov 202311:04 amRNSForm 8.3 - TMT Acquisition PLC
8th Nov 20235:52 pmRNSForm 8.3 - TMT Acquisition plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.